638217-08-0 Usage
Uses
Used in Pharmaceutical Development:
6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide is utilized as a key intermediate in the synthesis of pharmaceuticals for various therapeutic purposes. Its presence in the molecular structure of drugs can contribute to their efficacy and selectivity, making it an essential component in drug discovery and development processes.
Used in Organic Synthesis:
In the field of organic synthesis, 6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide is employed as a versatile building block. Its chemical reactivity and structural features allow for the creation of a wide range of organic compounds, facilitating the exploration of new chemical space and the advancement of synthetic methodologies.
Used in Medicinal Chemistry Research:
6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide is also used as a research tool in medicinal chemistry. It aids scientists in understanding the structure-activity relationships of potential drug candidates, thereby guiding the optimization of lead compounds and the design of more effective therapeutic agents.
Used in Drug Design:
6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide is applied in drug design to create novel molecules with specific pharmacological activities. Its incorporation into drug candidates can enhance their interaction with biological targets, potentially leading to improved potency, selectivity, and safety profiles.
Used in Chemical Biology:
In chemical biology, 6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide serves as a probe to study the mechanisms of biological processes. Its ability to modulate protein function or cellular pathways can provide insights into disease mechanisms and identify new therapeutic targets.
Used in Analytical Chemistry:
6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide can be employed in the development of analytical methods for detecting and quantifying biologically relevant molecules. Its chemical properties may be leveraged to improve the sensitivity and selectivity of analytical techniques, contributing to advancements in diagnostics and biomarker research.
Check Digit Verification of cas no
The CAS Registry Mumber 638217-08-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,8,2,1 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 638217-08:
(8*6)+(7*3)+(6*8)+(5*2)+(4*1)+(3*7)+(2*0)+(1*8)=160
160 % 10 = 0
So 638217-08-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO3/c1-6-10(11(14)12-2)8-4-3-7(13)5-9(8)15-6/h3-5,13H,1-2H3,(H,12,14)
638217-08-0Relevant articles and documents
Synthetic method of VEGFR inhibitor furoquitinib and benzofuran intermediate thereof
-
, (2021/05/01)
The invention discloses a synthetic method of a VEGFR inhibitor furoquitinib and a benzofuran intermediate thereof. The synthetic method of the VEGFR inhibitor furoquitinib comprises the following steps of S1, halogenation, S2, acylation, S3, coupling, S4
METHODS OF PREPARING A VEGF-R INHIBITOR
-
Page/Page column 25, (2010/11/27)
The present invention relates to methods for preparing a compound of formula (7), which is useful as a modulator and/or inhibitor of protein kinases. The present invention also relates to intermediate compounds useful in the preparation of a compound of f
NOVEL QUINOLINE DERIVATIVES
-
Page/Page column 51, (2008/06/13)
The invention relates to compounds represented by Formula (I): and to pharmaceutically acceptable salts or solvates of said compounds, wherein each of A, R3-8, X3, X5, m, and n are defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula (I).
Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
-
, (2008/06/13)
The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE
-
Page 51, (2010/02/04)
The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
